Biovia

What Biovia does

BIOVIA is the scientific software brand of Dassault Systèmes SE, the French multinational publicly traded on Euronext Paris (DSY.PA). Originally founded in 2001 and acquired by Dassault Systèmes in 2016, BIOVIA provides a portfolio of enterprise scientific applications built on the 3DEXPERIENCE platform. The portfolio spans six disciplines — Biosciences, Laboratory Informatics, Materials Science & Engineering, Scientific Informatics, Regulatory Management, and Quality Management — with core products including BIOVIA Discovery Studio (molecular modeling and simulation), BIOVIA ONE Lab (LIMS/ELN/instrument integration), BIOVIA Pipeline Pilot (scientific data science and ML), BIOVIA Materials Studio (in-silico materials design), BIOVIA Scientific AI (generative AI and Virtual Advisors), BIOVIA Generative Therapeutics Design, BIOVIA Formulation Design, BIOVIA Discoverant (manufacturing analytics), BIOVIA Quality, and BIOVIA Regulatory, supported by COSMO-RS thermodynamic modeling.

The platform's central technical premise is a unified scientific data model connecting research, development, manufacturing, and quality, enabling Virtual Twin Experiences that simulate and predict real-world behavior of molecules, formulations, materials, and processes before physical experimentation. Recent AI capabilities include generative AI for novel molecular and materials design, LLMs powering Virtual Advisors for formulation and lab workflows, and integration of AlphaFold protein-structure models via the OpenFold consortium, with accelerated AI inference delivered through a flagship partnership with NVIDIA.

BIOVIA generates revenue primarily through enterprise software licensing and subscriptions, supplemented by contract research and professional services, with a freemium entry point (Discovery Studio Visualizer) feeding enterprise deployments and discounted academic licensing available to institutions. It sells through direct enterprise sales globally, targeting large pharmaceutical and biotech companies, consumer packaged goods firms, chemicals and materials companies, and transportation/mobility industrials, with disclosed enterprise customers including Pfizer, AstraZeneca, Amgen, Gilead, Sanofi, Bayer, Hovione, Aboca, L'Oréal, Procter & Gamble, Unilever, Dow Chemical, Airbus, General Motors, and Tesla.

Name

Biovia

Legal name

Dassault Systèmes SE

Website

https://3dsbiovia.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BIOVIA, a brand of Dassault Systèmes SE, provides enterprise scientific software on the 3DEXPERIENCE platform — including molecular modeling, lab informatics, materials simulation, and AI-driven drug discovery — for pharmaceutical, biotech, consumer packaged goods, chemicals, and mobility customers.

Ownership category

akta.pro rank

Product category

Scientific R&D Software

NAICS

Software Publishers (51321)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)

Keywords

• Scientific software
• Molecular modeling
• Lab informatics
• Drug discovery
• Materials simulation

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Enterprise Software Licenses and Subscriptions: BIOVIA generates primary revenue through enterprise software licensing and subscription fees. Products include Discovery Studio (with free visualizer and paid full version), Materials Studio, Pipeline Pilot, ONE Lab, and other specialized scientific software. Academic institutions can access discounted licensing options with institutional pricing. The model is primarily subscription-based for enterprise deployments on the 3DEXPERIENCE platform.
2. Contract Research and Professional Services: BIOVIA offers contract research services and professional services offerings to augment software deployments. This includes implementation services, training, and specialized scientific consulting for pharmaceutical and materials science applications.

Pricing tiers

Distribution channels3 records

Marketing channels9 records

Core offering

BIOVIA develops and sells enterprise scientific software on the 3DEXPERIENCE platform for life sciences, materials science, and drug discovery. Core products include molecular modeling and simulation (Discovery Studio), lab informatics (ONE Lab), scientific data science (Pipeline Pilot), materials simulation (Materials Studio), and AI-powered scientific research (Scientific AI). The portfolio also covers formulation design, manufacturing analytics, quality and regulatory management for pharmaceutical, biotech, consumer packaged goods, and industrial customers.

Product overview

BIOVIA is a comprehensive scientific software portfolio from Dassault Systèmes offering a platform-plus-modules architecture built on the 3DEXPERIENCE platform. The core platform, 3DEXPERIENCE BIOVIA, provides a unified data model connecting specialized solutions including BIOVIA Discovery Studio (molecular modeling and simulation), BIOVIA ONE Lab (comprehensive lab informatics beyond traditional LIMS), BIOVIA Pipeline Pilot (scientific data science and ML), BIOVIA Materials Studio (materials design), and BIOVIA Scientific AI (generative AI and LLMs for scientific R&D). Key modules include BIOVIA Generative Therapeutics Design for AI-powered molecule creation, BIOVIA Formulation Design for formulation workflows, BIOVIA Insight for analytics, and BIOVIA Discoverant for manufacturing analytics. The portfolio is organized across six interconnected disciplines: Biosciences, Laboratory Informatics, Materials Science & Engineering, Scientific Informatics, Regulatory Management, and Quality Management. The platform enables the 'molecule to manufacturing' approach through Virtual Twin Experiences that connect virtual modeling with real-world experimentation.

Differentiator

Problem solved

Functional benefit

Brands

• BIOVIA Discovery Studio: Molecular modeling and simulation software for drug discovery and biotherapeutic design.
• BIOVIA ONE Lab
• BIOVIA Pipeline Pilot
• BIOVIA Materials Studio
• BIOVIA Scientific AI
• BIOVIA Formulation Design
• BIOVIA Discoverant
• BIOVIA Generative Therapeutics Design

Products and services

• 3DEXPERIENCE BIOVIA Open, collaborative platform providing a unified data model that connects all BIOVIA solutions across the product development lifecycle from research to manufacturing.
• BIOVIA Discovery Studio Simulation Molecular modeling and simulation software for life sciences research and drug discovery, enabling visualization and analysis of molecular structures. Includes a free visualizer version and a paid full license.
• BIOVIA ONE Lab Comprehensive lab informatics suite that goes beyond traditional LIMS, including guided procedure execution, electronic lab notebooks (ELN), instrument and inventory management, and integration with AI analytics.
• BIOVIA Pipeline Pilot Scientific data science and machine learning platform that enables scientists to gather, process, and report experimental data with automated workflows and error checking.
• BIOVIA Materials Studio In-silico design and simulation tool for materials science, allowing researchers to predict and understand properties and behavior of new materials at atomic and molecular levels.
• BIOVIA Scientific AI Specialized AI platform for scientific R&D that integrates generative AI and large language models to deliver actionable insights and accelerate discovery across biological, chemical, and materials systems.
• BIOVIA Generative Therapeutics Design Generative AI solution for creating and optimizing novel therapeutic molecules with desired properties for faster drug development.
• BIOVIA Formulation Design AI-powered formulation development software for the consumer packaged goods (CPG) industry that streamlines formula and recipe development workflows, enhances sustainability, and improves regulatory compliance.
• BIOVIA Insight Advanced analytics application that integrates with ONE Lab for deeper scientific insights and data visualization.
• COSMO-RS Thermodynamic modeling solution for predicting chemical behavior and properties of mixtures.
• BIOVIA Quality AI-based end-to-end digital quality management system ensuring product quality and safety, including management of deviations and CAPAs.
• BIOVIA Regulatory Regulatory management solutions for document authoring with structured content, managing SOPs, and ensuring compliance with global regulatory standards.
• BIOVIA Contract Research Contract research services that augment BIOVIA software deployments, providing specialized scientific expertise and project-based engagements for pharmaceutical and materials science applications.
• BIOVIA Services Offering Professional services including implementation, training, and specialized scientific consulting that accompany BIOVIA software deployments.

Quantifiable outcome

• Scientists saved 1.5 hours per experiment on average using BIOVIA Pipeline Pilot
• +3 more outcomes

Named customers15 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature12 records

Partnerships

Two partnerships are on record, tiered core and flagship.

• OpenFold ConsortiumcoreStrategic or Co-development Partner · 1 November 2022Dassault Systèmes, through its BIOVIA and MEDIDATA brands, joined the OpenFold consortium in November 2022 to integrate AlphaFold AI models into its 3DEXPERIENCE platform for pharmaceutical research. This partnership advances AI-powered drug discovery capabilities by incorporating state-of-the-art protein structure prediction into BIOVIA's scientific AI portfolio.
• NVIDIAflagshipTechnology or IntegrationBIOVIA has a strategic partnership with NVIDIA to combine NVIDIA-accelerated AI inference with BIOVIA's world-class scientific AI and modeling capabilities. This partnership enables the next generation of therapeutics and high-performance materials development within a collaborative 3D universe, providing accelerated AI computation for molecular discovery and simulation workloads.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Sartorius: Global bioprocessing and lab products company with a growing digital/software footprint (including data analytics and bioprocess software). Comparable as a broad incumbent serving biopharma R&D and manufacturing, with partial overlap with BIOVIA's manufacturing analytics (Discoverant) capabilities.
• Revvity (formerly PerkinElmer): Large life sciences and diagnostics company with software, informatics, and lab automation offerings (Signals, ChemDraw, Spotfire). A broad incumbent that overlaps with BIOVIA across lab informatics and scientific data analytics, though spread across a wider portfolio including instruments and reagents.

Direct peers

• IDBS: Life sciences R&D data management and analytics platform (Polar, BioPharma Lifecycle Management) directly comparable to BIOVIA ONE Lab, Pipeline Pilot, and Scientific Informatics. Competes for the same ELN and lab informatics RFPs in biopharma.
• LabVantage: Enterprise LIMS provider with capabilities across laboratory informatics, ELN, and quality management. Direct overlap with BIOVIA's Laboratory Informatics and Quality Management disciplines, particularly in regulated pharma manufacturing environments.
• Veeva Systems: Life sciences cloud platform spanning R&D (Vault RIM, Vault Quality), clinical (Vault CDB, Vault EDC), and commercial. Overlaps with BIOVIA's Regulatory and Quality Management disciplines, and is a leading enterprise software standard across the same pharma customer base.
• Certara: Drug development software and services company spanning biosimulation, regulatory science, and clinical pharmacology. Directly comparable to BIOVIA's Regulatory Management and biosimulation capabilities, and competes for similar pharma R&D and regulatory affairs budgets.
• Dotmatics: Unified scientific informatics platform (including SnapGene, GraphPad Prism, and the Dotmatics enterprise platform) that competes with BIOVIA across ELN, data management, and scientific workflows. Recently backed by Insight Partners with a focus on consolidating life sciences R&D software — direct overlap with BIOVIA's Laboratory Informatics discipline.
• Benchling: Cloud-native life sciences R&D platform offering ELN, LIMS, and molecular biology capabilities directly overlapping with BIOVIA ONE Lab and Scientific Informatics. Targets the same biotech and pharma buyers with a modern, API-first architecture and is one of BIOVIA's most aggressive competitors in net-new enterprise deals.
• Schrödinger: Computational chemistry and molecular simulation platform (LiveDesign) serving pharma and materials science accounts. Directly comparable to BIOVIA Discovery Studio and Materials Studio in physics-based modeling, and increasingly competing in AI-driven molecular design.
• OpenEye (Cadence Molecular Sciences): Molecular modeling and simulation software (OELib, Orion, Cadence) for pharmaceutical research. Directly comparable to BIOVIA Discovery Studio in computational chemistry and structure-based drug design, with growing overlap in cloud-native scientific informatics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/3dsbiovia
• YouTubeyoutube.com/c/BIOVIA1
• Facebookfacebook.com/3dsBIOVIA
• LinkedInlinkedin.com/company/biovia
• Instagraminstagram.com/3dsbiovia

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biovia